Male breast cancer has distinct alterations in the tumor genome that may suggest potential treatment targets, according to a study by Weill Cornell Medicine investigators.
A team led by Dr. Samie Jaffrey, the Greenberg-Starr Professor of Pharmacology at Weill Cornell Medicine, has been awarded a three-year, $1.65 million grant for RNA research under a biotechnology-development program run by the U.S. National Science Foundation.
Faculty, staff and community partners are working together to address community needs — and they’re getting students involved with support from Engaged Opportunity Grants from the Einhorn Center for Community Engagement.
Early onset heart failure is alarmingly common in urban Haiti – over 15-fold higher than previously estimated – according to a study conducted by Weill Cornell Medicine researchers in partnership with the Haitian medical organization GHESKIO.
An interdisciplinary collaboration has designed a way to “cloak” proteins so they can be captured by lipid nanoparticles and delivered into living cells, where the proteins uncloak and exert their therapeutic effect.
Researchers have developed an AI tool that uses machine learning and large language models to identify treatment options based on patients’ diagnoses, demographic information and priorities.
Weill Cornell Medicine scientists have developed an innovative human neuron model that robustly simulates the spread of tau protein aggregates in the brain – a process that drives cognitive decline in Alzheimer’s disease and frontotemporal dementia.